ERBB2 and pancreatic neoplasm: In order to determine the relative expression and clinical relevance of HER2 and HER3 in pancreatic cancer, we utilized the pancreatic cancer patients tumor tissues (obtained from Rapid Autopsy program at UNMC) for immunohistochemical analysis.